Eli Lilly's experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage trials, the company said on Wednesday, as it seeks to widen its lead in the ...
Discover how to design compact, low-power continuous glucose monitors that enhance patient comfort and extend battery life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback